| De novo mutations in epileptic encephalopathies. AS Allen, SF Berkovic, P Cossette, N Delanty, D Dlugos, EE Eichler, ... Nature 501 (7466), 217, 2013 | 1542 | 2013 |
| Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee and … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1252-1260, 2004 | 729* | 2004 |
| Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1261-1273, 2004 | 699 | 2004 |
| Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder W Du, JF Bautista, H Yang, A Diez-Sampedro, SA You, L Wang, P Kotagal, ... Nature genetics 37 (7), 733-738, 2005 | 655 | 2005 |
| De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies S Appenzeller, R Balling, N Barisic, S Baulac, H Caglayan, D Craiu, ... The American Journal of Human Genetics 95 (4), 360-370, 2014 | 345 | 2014 |
| Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy AM Kanner, E Ashman, D Gloss, C Harden, B Bourgeois, JF Bautista, ... Epilepsy currents 18 (4), 269-278, 2018 | 344* | 2018 |
| Special Articles-Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1261-1273, 2004 | 284* | 2004 |
| Erratum. Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of … J French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Epilepsia 45 (11), 1299-1299, 2004 | 284* | 2004 |
| Special Articles-Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1252-1260, 2004 | 276* | 2004 |
| Special Report: Practice Parameters. Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New-Onset Epilepsy: Report of the TTA and QSS Subcommittees of … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Epilepsia 45 (5), 401-409, 2004 | 276* | 2004 |
| Ultra-rare genetic variation in common epilepsies: a case-control sequencing study AS Allen, ST Bellows, SF Berkovic, J Bridgers, R Burgess, G Cavalleri, ... The Lancet Neurology 16 (2), 135-143, 2017 | 187 | 2017 |
| Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: The TTA and QS Subcommittees of the AAN and the American Epilepsy Society JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... NEUROLOGY-MINNEAPOLIS- 62 (8), 1252-1260, 2004 | 187* | 2004 |
| Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new‐onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and … JA French, AM Kanner, J Bautista, B Abou‐Khalil, T Browne, CL Harden, ... Epilepsia 45 (5), 401-409, 2004 | 179 | 2004 |
| Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and … JA French, AM Kanner, J Bautista, B Abou‐Khalil, T Browne, CL Harden, ... Epilepsia 45 (5), 401-409, 2004 | 179 | 2004 |
| Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and … JA French, AM Kanner, J Bautista, B Abou‐Khalil, T Browne, CL Harden, ... Epilepsia 45 (5), 410-423, 2004 | 170 | 2004 |
| Focal cortical dysplasia and intractable epilepsy in adults: clinical, EEG, imaging, and surgical features JF Bautista, N Foldvary-Schaefer, WE Bingaman, HO Lüders Epilepsy research 55 (1), 131-136, 2003 | 145 | 2003 |
| The NINDS epilepsy research benchmarks MS Kelley, MP Jacobs, DH Lowenstein Epilepsia 50 (3), 579, 2009 | 105 | 2009 |
| Evidence for a shared genetic susceptibility to migraine and epilepsy MR Winawer, R Connors, EPGP Investigators Epilepsia 54 (2), 288-295, 2013 | 98 | 2013 |
| Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy Epilepsy Phenome/Genome Project & Epi4K Consortium, AS Allen, ... Annals of neurology 78 (2), 323-328, 2015 | 83 | 2015 |
| American Epilepsy Society. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment … JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ... Neurology 62 (8), 1261-1273, 2004 | 69 | 2004 |
